Human Papillomavirus-Lessons From History and Challenges for the Future

被引:2
作者
Shepherd, Lynn J. [1 ]
Bryson, S. C. Peter [1 ]
机构
[1] Queens Univ, Dept Obstet & Gynaecol, Kingston, ON, Canada
关键词
HPV; cervical cancer screening; cervical dysplasia; vaccine; cancer prevention;
D O I
10.1016/S1701-2163(16)32997-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human papillomavirus (HPV) is the most common sexually transmitted infection, and HPV-associated cervical cancer is a significant cause of morbidity and mortality worldwide. Recent advances in molecular biology have facilitated testing for HPV infection. Over the last decade, national and international cervical cancer screening programs have added HPV testing to their guidelines. The use of HPV prophylactic and therapeutic immunization may expand the need for systematic HPV testing to help define eligible subgroups for intervention. Given the worldwide variation in HPV subtype prevalence, basic Pap testing will continue to play an important role in cervical cancer screening, and methods to improve Pap smear sensitivity may help to improve screening in the future. This review focuses on the genetics and cellular biology of HPV infection, the natural history and prevalence of HPV infections, cervical cancer screening around the world and in Canada in particular, and evolving research to improve screening methods.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 82 条
  • [1] ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415
  • [2] Agence de la Sante and des services sociaux de Montreal, VACC CONTR VIR PAP H
  • [3] Liquid compared with conventional cervical cytology - A systematic review and meta-analysis
    Arbyn, Marc
    Bergeron, Christine
    Klinkhamer, Paul
    Martin-Hirsch, Pierre
    Siebers, Albertus G.
    Bulten, Johan
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (01) : 167 - 177
  • [4] The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma
    Bahnassy, Abeer
    Zekri, Abdel
    Saleh, Maha
    Lotayef, Mohammad
    Moneir, Manar
    Shawki, Osama
    [J]. BMC CLINICAL PATHOLOGY, 2007, 7
  • [5] BC Cancer Agency, CERV CANC SCR PROGR
  • [6] BCHealthFiles, HUM PAP HPV GRAD 6 9
  • [7] Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
    Bulkmans, NWJ
    Rozendaal, L
    Snijders, PJF
    Voorhorst, FJ
    Boeke, AJP
    Zandwijken, GRJ
    van Kemenade, FJ
    Verheijen, RHM
    von Groningen, K
    Boon, ME
    Keuning, HJF
    van Ballegooijen, M
    van den Brule, AJC
    Meijer, CJLM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (01) : 94 - 101
  • [8] Politics, parents, and prophylaxis - Mandating HPV vaccination in the United States
    Charo, R. Alta
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1905 - 1908
  • [9] The estimated direct medical cost of sexually transmitted diseases among American youth, 2000
    Chesson, HW
    Blandford, JM
    Gift, TL
    Tao, GY
    Irwin, KL
    [J]. PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2004, 36 (01) : 11 - 19
  • [10] Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
    Clavel, C
    Masure, L
    Bory, JP
    Putaud, I
    Mangeonjean, C
    Lorenzato, M
    Nazeyrollas, P
    Gabriel, R
    Quereux, C
    Birembaut, P
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1616 - 1623